{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:15:33Z","timestamp":1787019333262,"version":"build-2736575974"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"NEXTGENERATIONEU (NGEU) by the Ministry of University and Research (MUR), National Recovery and Resilience Plan","award":["project MNESYS (PE0000006)"],"award-info":[{"award-number":["project MNESYS (PE0000006)"]}]},{"name":"European Union\u2013Next Generation EU\u2013NRRP M6C2\u2013Investment 2.1 Enhancement and strengthening of biomedical research in the NHS","award":["PNRR-MAD-2022-12376769"],"award-info":[{"award-number":["PNRR-MAD-2022-12376769"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Migraine is a disabling neurovascular disorder characterized by recurrent attacks that lead to extracranial and visual involvement. Several studies have investigated the retinal vasculature features in individuals with migraine, but there have been conflicting results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate retinal structure in migraine patients before (T0) and after 6-month therapy (T1) with anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs), using optical coherence tomography (OCT) imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A case-control and longitudinal study was conducted between January 2021 and December 2023, including 20 eyes from 10 healthy controls (HCs) and 32 eyes of 16 patients with migraine and treated with anti-CGRP mAbs according to AIFA criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients underwent OCT angiography (OCT-A) to assess retinal vessel density (VD) and spectral-domain OCT (SD-OCT) to evaluate central retinal thickness, macular structure, and peripapillary retinal nerve fiber layer thickness. These parameters were assessed in both groups at T0 and again after 6\u2009months (T1) as part of routine clinical care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All migraineurs exhibited a significant reduction in disease disability at T1, as assessed by clinical parameters. OCT data analysis revealed that individuals with migraine showed a significant increase in temporal retinal nerve fiber layer (RNFL) thickness and a reduction in nasal RNFL thickness compared to HCs. No differences in retinal circulation were observed between the groups at baseline. At T1, RNFL thickness remained sustained in the superior temporal sector, while the percentage VD of the superficial capillary plexus and radial peripapillary capillary significantly increased in the nasal perifoveal, inferior temporal, and hemi-inferior subregions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study suggests that specific retinal structural changes could precede vascular dysfunction in migraine and can be detected early by combining SD-OCT and OCT-A acquisitions. Short-term treatment with anti-CGRP mAbs may exert neuroprotective effects, potentially preventing permanent ocular damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>\n                      EyeHEAD Study (Trial registration number AIFA July\/2024: IT 1735,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.aifa.gov.it\/registro-studi-osservazionali\">www.aifa.gov.it\/registro-studi-osservazionali<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562864251347277","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T06:57:13Z","timestamp":1750748233000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the impact of anti-CGRP monoclonal antibodies on retinal features in migraine patients: a retrospective optical coherence tomography study"],"prefix":"10.1177","volume":"18","author":[{"given":"Massimo","family":"Cesareo","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-8211","authenticated-orcid":false,"given":"Alessio","family":"Martucci","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bovenzi","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lombardo","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-4240","authenticated-orcid":false,"given":"Francesca","family":"Pistoia","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria Carla","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Regional Referral Headache Center, Tor Vergata University Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Stefani","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"},{"name":"IRCCS Santa Lucia Foundation, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-2017","authenticated-orcid":false,"given":"Maria","family":"Albanese","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, via Montpellier 1, Rome 00133, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05227-w"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01709.x"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16132169"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.06.012"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3914"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.73717"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2017.06.002"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01561-w"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11226-4"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04669-y"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207292"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051228"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.4081\/cc.2024.15762"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1088036"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113766"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204693"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17454"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11697-z"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1241778"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14750"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.suppl_1.S20"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2008.4.4.158"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002774"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2016.12.014"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000937"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13486"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14654"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2016.30.2.134"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12616"},{"key":"e_1_3_4_34_2","first-page":"251","article-title":"Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina","volume":"51","author":"Bronzetti E","year":"2007","unstructured":"Bronzetti E, Artico M, Kovacs I, et al. Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur J Histochem 2007; 51: 251\u2013260.","journal-title":"Eur J Histochem"},{"key":"e_1_3_4_35_2","first-page":"1159","article-title":"Characterization and localization of the rabbit ocular calcitonin gene- related peptide (CGRP)-receptor component protein (RCP)","volume":"41","author":"Rosenblatt MI","year":"2000","unstructured":"Rosenblatt MI, Dahl GP, Dickerson IM. Characterization and localization of the rabbit ocular calcitonin gene- related peptide (CGRP)-receptor component protein (RCP). Invest Ophthalmol Vis Sci 2000; 41: 1159\u20131167.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"e_1_3_4_36_2","first-page":"264","article-title":"A potential preclinical migraine model: CGRP-sensitized mice","volume":"1","author":"Russo AF","year":"2009","unstructured":"Russo AF, Kuburas A, Kaiser EA, et al. A potential preclinical migraine model: CGRP-sensitized mice. Mol Cell Pharmacol 2009; 1(5): 264\u2013270.","journal-title":"Mol Cell Pharmacol"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000702"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251347277","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251347277","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251347277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:05:13Z","timestamp":1767675913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251347277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":36,"alternative-id":["10.1177\/17562864251347277"],"URL":"https:\/\/doi.org\/10.1177\/17562864251347277","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"17562864251347277"}}